Pierre Fontana: Launching the European Interuniversity Certificate in Clinical Haemostasis
Pierre Fontana, Academic Director of the Department of Medicine at Geneva University Hospitals (HUG), shared a post on LinkedIn:
“European Interuniversity Certificate in Clinical Haemostasis
We are pleased to announce that the first cohort of students is now starting the European Interuniversity Certificate in Clinical Haemostasis, a unique program designed for healthcare professionals and researchers seeking advanced expertise in bleeding and thrombotic disorders.
What makes this program unique?
- A European collaboration bringing together leading universities and experts in haemostasis.
- A multidisciplinary curriculum bridging clinical practice, laboratory medicine, and research.
- A flexible learning format adapted to the needs of busy professionals.
- A strong focus on clinical cases and real-world decision-making.
- Recognized as a Certificate of Advanced Studies (CAS) by the Université de Genève
The program is coordinated by Université Claude Bernard Lyon 1, serving as the leading university of this European initiative.
This certificate is aimed at physicians, biologists, pharmacists, and healthcare professionals involved in the diagnosis and management of haemostatic disorders.
It represents an important milestone toward the standardization of training in clinical haemostasis and the recognition of this field as a fully established medical specialty.
Read Program Details and Application Information.
Reaf Full program description.”
Stay updated with Hemostasis Today.
-
Nov 18, 2026, 15:11Vansh Yaduvanshi: Why Compatible Blood Groups Do Not Always Mean Compatible Blood
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: The Ecological Transition in Thrombosis and Haemostasis